Laxmi Organic Industries
- P/E
- 35.68
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 4.72%
- Debt to Equity
- 0.27
- EPS (TTM)
- ₹4.54
- Book Value
- ₹71.45
- Market Cap
- —
- P/E (TTM)
- 35.68
- P/B
- 2.27
- ROE
- 4.11%
- Dividend Yield
- 0.19%
- EBITDA
- ₹187 Cr
- 52W High
- ₹203.80
- 52W Low
- ₹107.60
- Day Range
- ₹155.30 – ₹162.73
- Volume
- 8,11,100
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹161.98 | 35.68 | ₹4,414 Cr | 2.27 | 0.19% | 4.11% | 4.72% | ₹3,122 Cr | ₹126 Cr | |
| Median 8 companies | ₹1,559.55 | 46.36 | ₹20,474 Cr | 4.68 | 0.21% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 43
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 22
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 38
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 46
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 44
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 47
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
6- Stock is trading at 2.61 times its book value
- The company has delivered a poor sales growth of 9.99% over past five years.
- Company has a low return on equity of 5.84% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 12.1% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.05%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 7 | 3 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 7 | 0 | 3 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.49
- Neutral
- MACD (12,26,9)
- −5.65
- Bearish
- SMA (50)
- 172.23
- Bearish
- SMA (200)
- 155.18
- Bullish
As of
Analyst Rating
0 of 2 analysts rate Buy, 0 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +10.52% |
|---|---|
| 5Y | +10.00% |
| 3Y | +0.59% |
| 1Y | −4.62% |
| TTM | +5.47% |
Net profit
| 10Y | +11.33% |
|---|---|
| 5Y | −9.06% |
| 3Y | −14.18% |
| 1Y | −30.70% |
| TTM | +26.00% |
Operating cash flow
| 10Y | +8.14% |
|---|---|
| 5Y | +10.55% |
| 3Y | −4.19% |
| 1Y | +62.04% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.60 pp |
|---|---|
| 5Y | −6.40 pp |
| 3Y | −2.83 pp |
| 1Y | −3.54 pp |
| TTM | +0.06 pp |
Revenue by year
| Mar 2017 | ₹1,076 Cr |
|---|---|
| Mar 2018 | ₹1,376 Cr |
| Mar 2019 | ₹1,569 Cr |
| Mar 2020 | ₹1,534 Cr |
| Mar 2021 | ₹1,768 Cr |
| Mar 2022 | ₹3,084 Cr |
| Mar 2023 | ₹2,797 Cr |
| Mar 2024 | ₹2,865 Cr |
| Mar 2025 | ₹2,985 Cr |
| Mar 2026 | ₹2,847 Cr |
Net profit by year
| Mar 2017 | ₹72.00 Cr |
|---|---|
| Mar 2018 | ₹76.00 Cr |
| Mar 2019 | ₹72.00 Cr |
| Mar 2020 | ₹70.00 Cr |
| Mar 2021 | ₹127 Cr |
| Mar 2022 | ₹256 Cr |
| Mar 2023 | ₹125 Cr |
| Mar 2024 | ₹121 Cr |
| Mar 2025 | ₹114 Cr |
| Mar 2026 | ₹79.00 Cr |
Analyst Forecasts
AI News Digest
TL;DR: Laxmi Organic is delivering strong profit growth with Q1FY27 PAT up 216% YoY to ₹677 Mn on 40% revenue growth and margin expansion in both segments. FY26 full-year revenue crossed ₹28 Bn. No identifiable headwinds in recent news flow.
- Q1FY27 PAT surges 216% YoY Jul 29
Net profit jumped 216% YoY to ₹677 Mn in Q1FY27, driven by 40% revenue growth and significant margin expansion across both Essentials and Specialties segments.
- Q1FY26 profit also surged Jul 29
Laxmi Organic reported Q1FY26 net profit of ₹633 Mn, reflecting higher revenue and improved operational efficiency, establishing a strong base for continued growth.
- FY26 revenue and dividend declared Jul 14
FY26 standalone revenue stood at ₹28,085.32 Mn with net profit of ₹792.58 Mn. Board recommended a final dividend of ₹0.30 per share.
- Q1FY27 earnings call hosted Jul 30
Laxmi Organic held an investor meet on July 30, 2026 at 2:00 PM IST to discuss Q1 FY27 results, led by MD & CEO Dr. Rajan Venkatesh and CFO Amit Jain.
- BRSR filed for FY26 Jul 14
Laxmi Organic filed its Business Responsibility & Sustainability Report for FY26, detailing ESG performance, governance practices, and material topics.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 729 | 652 | 694 | 792 | 718 | 771 | 786 | 710 | 693 | 700 | 719 | 735 | 968 |
| Expenses | 652 | 613 | 642 | 702 | 647 | 697 | 712 | 651 | 662 | 663 | 669 | 682 | 854 |
| Operating Profit | 77 | 39 | 52 | 90 | 71 | 75 | 75 | 59 | 31 | 37 | 50 | 54 | 114 |
| OPM % | 11% | 6% | 8% | 11% | 10% | 10% | 10% | 8% | 4.4% | 5% | 7% | 7% | 12% |
| Other Income | 4 | 8 | 5 | 8 | 12 | 7 | 6 | 1 | 6 | 4 | 3 | 3 | 3 |
| Interest | 5 | 2 | 1 | −1 | 3 | 8 | 2 | 7 | 5 | 6 | 7 | 5 | 4 |
| Depreciation | 21 | 28 | 28 | 31 | 26 | 27 | 31 | 40 | 17 | 20 | 20 | 19 | 22 |
| PBT | 56 | 18 | 30 | 68 | 54 | 46 | 47 | 13 | 14 | 16 | 26 | 32 | 92 |
| Tax % | 31% | 39% | 8% | 35% | 36% | 39% | 38% | −64% | −51% | 29% | 2% | 34% | 26% |
| Net Profit | 38 | 11 | 27 | 44 | 34 | 28 | 29 | 22 | 21 | 11 | 25 | 22 | 68 |
| EPS (₹) | 1.44 | 0.4 | 0.99 | 1.61 | 1.24 | 1.02 | 1.06 | 0.79 | 0.77 | 0.4 | 0.92 | 0.78 | 2.44 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,797 | 2,865 | 2,985 | 2,847 | 3,122 |
| Expenses | 988 | 966 | 957 | 1,222 | 1,414 | 1,418 | 1,548 | 2,713 | 2,548 | 2,609 | 2,699 | 2,674 | 2,867 |
| Operating Profit | 86 | 80 | 119 | 154 | 155 | 117 | 220 | 371 | 248 | 256 | 286 | 172 | 255 |
| OPM % | 8% | 8% | 11% | 11% | 10% | 8% | 12% | 12% | 9% | 9% | 10% | 6% | 8% |
| Other Income | 1 | 2 | 2 | 3 | 6 | 30 | 4 | 15 | 12 | 28 | 19 | 15.31 | 13 |
| Interest | 26 | 19 | 11 | 12 | 19 | 17 | 19 | 19 | 15 | 7 | 20 | 22 | 21 |
| Depreciation | 30 | 29 | 28 | 31 | 44 | 49 | 47 | 49 | 72 | 107 | 124 | 77 | 81 |
| PBT | 31 | 34 | 82 | 113 | 98 | 81 | 158 | 318 | 173 | 171 | 161 | 88 | 166 |
| Tax % | 31% | 22% | 13% | 33% | 26% | 13% | 20% | 19% | 28% | 29% | 29% | 10% | — |
| Net Profit | 21 | 27 | 72 | 76 | 72 | 70 | 127 | 256 | 125 | 121 | 114 | 79 | 126 |
| EPS (₹) | 21.12 | 26.56 | 71.5 | 75.63 | 14.46 | 15.57 | 4.82 | 9.72 | 4.7 | 4.37 | 4.1 | 2.86 | 4.54 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 11% | 10% | 7% | 11% | 14% | 12% | 10% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 | 55 |
| Reserves | 199 | 225 | 295 | 369 | 400 | 382 | 982 | 1,248 | 1,359 | 1,742 | 1,851 | 1,930 |
| Borrowings | 249 | 221 | 104 | 215 | 175 | 159 | 149 | 139 | 406 | 143 | 258 | 543 |
| Other Liabilities | 152 | 176 | 240 | 300 | 389 | 484 | 654 | 825 | 595 | 887 | 880 | 915 |
| Total Liabilities | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,265 | 2,412 | 2,827 | 3,045 | 3,443 |
| Fixed Assets | 226 | 215 | 202 | 293 | 346 | 338 | 325 | 394 | 715 | 879 | 1,166 | 1,481 |
| CWIP | 25 | 40 | 61 | 30 | 31 | 67 | 148 | 374 | 447 | 444 | 398 | 652 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 23 | 126 | 148 | 37 |
| Other Assets | 358 | 377 | 386 | 571 | 637 | 664 | 1,361 | 1,492 | 1,228 | 1,378 | 1,332 | 1,274 |
| Total Assets | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,265 | 2,412 | 2,827 | 3,045 | 3,443 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 80 | 150 | −7 | 188 | 196 | 106 | 46 | 199 | 561 | 108 | 175 |
| Investing | — | −21 | −37 | −85 | −123 | −56 | −641 | 95 | −384 | −490 | −268 | −404 |
| Financing | — | −57 | −107 | 85 | −63 | −123 | 527 | −124 | 232 | −42 | 90 | 247 |
| Net Cash Flow | — | 1 | 6 | −7 | 2 | 16 | −7 | 16 | 47 | 30 | −70 | 18 |
| Free Cash Flow | — | 53 | 114 | −95 | 90 | 118 | −10 | −243 | −277 | 314 | −286 | −427 |
| CFO/OP | — | 90 | 113 | 13 | 139 | 181 | 60 | 27 | 100 | 234 | 47 | 107 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 67 | 79 | 86 | 76 | 86 | 90 | 79 | 74 | 74 | 66 | 67 |
| Inventory Days | 37 | 57 | 37 | 55 | 57 | 51 | 63 | 65 | 58 | 54 | 71 | 70 |
| Days Payable | 52 | 67 | 85 | 81 | 105 | 138 | 148 | 123 | 92 | 145 | 131 | 140 |
| Cash Conversion Cycle | 49 | 56 | 30 | 60 | 28 | −1 | 5 | 21 | 41 | −16 | 6 | −3 |
| Working Capital Days | 65 | 66 | 36 | 28 | 28 | 17 | −1 | 42 | 31 | 19 | 12 | 31 |
| ROCE % | — | 12% | 22% | 25% | 19% | 12% | 20% | 26% | 11% | 9% | 9% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Laxmi Organic Industries insights
62 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 28 Jul 2025
- 2 Mar 2026
- 23 Dec 2025
- 20 Nov 2025
- 24 Dec 2024
- 18 Dec 2024
- General announcements 26 Oct 2026
- General announcements 14 Oct 2026
Frequently Asked Questions about Laxmi Organic Industries
What does Laxmi Organic Industries Ltd do?
Where is Laxmi Organic Industries Ltd (LXCHEM) listed?
Which sector does Laxmi Organic Industries Ltd belong to?
What is the PE ratio of Laxmi Organic Industries Ltd?
What is the 52-week high and low of Laxmi Organic Industries Ltd?
Does Laxmi Organic Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Laxmi Organic Industries Ltd?
Company Information
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited. The company’s business operations are carried in over 30 countries including 11 offices located in India
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LXCHEM.md for Laxmi Organic Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.